BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31818145)

  • 1. Primary Central Nervous System Lymphoma in an Immunocompetent Patient Presenting as Multiple Cerebellar Lesions: A Case Report and Review of Literature.
    Galarza Fortuna GM; Dvir K; Febres-Aldana C; Schwartz M; Medina AM
    J Investig Med High Impact Case Rep; 2019; 7():2324709619893548. PubMed ID: 31818145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central Nervous System Lymphoma.
    Chukwueke UN; Nayak L
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):597-611. PubMed ID: 31229157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.
    Grommes C; Rubenstein JL; DeAngelis LM; Ferreri AJM; Batchelor TT
    Neuro Oncol; 2019 Feb; 21(3):296-305. PubMed ID: 30418592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar large B-cell lymphoma: a case report.
    Ghannam M; Mansour S; Jumah F; Berry B; Beard A
    J Med Case Rep; 2018 Nov; 12(1):341. PubMed ID: 30446015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
    Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy.
    Biswas A; Adhikari N; Bakhshi S; Gopinathan VR; Sharma MC
    Pediatr Neurosurg; 2019; 54(1):57-65. PubMed ID: 30669145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report.
    Guo Y; Li J; Li M; Li Z; Cui Y; Li Y; Zhao R; Han Q; Yang H; Ma C
    Medicine (Baltimore); 2024 Apr; 103(17):e37923. PubMed ID: 38669361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
    Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
    World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
    Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients].
    Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
    Olivier G; Clavert A; Lacotte-Thierry L; Gardembas M; Escoffre-Barbe M; Brion A; Cumin I; Legouffe E; Solal-Celigny P; Chabin M; Ingrand P; Colombat P; Delwail V
    Am J Hematol; 2014 Nov; 89(11):1024-9. PubMed ID: 25052698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous system lymphoma in a patient with systemic lupus erythematosus mimicking high-grade glioma: A case report and review of literature.
    Su L; Ding M; Chen L; Li C; Lao M
    Medicine (Baltimore); 2018 Jun; 97(23):e11072. PubMed ID: 29879076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary central nervous system lymphoma at the cerebellopontine angle mimicking a trigeminal schwannoma: A unique case report and literature review.
    Seevaratnam V; Li Y; Lee SLK; Olsson G
    J Clin Neurosci; 2018 Jun; 52():115-119. PubMed ID: 29656000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary central nervous system lymphoma in an immunocompetent patient: report of a case].
    Coronel F D; Gallardo V C; Gamargo G C
    Rev Med Chil; 2008 Apr; 136(4):491-5. PubMed ID: 18769792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of primary central nervous system lymphoma with the primary lesion in the hypothalamus: a case report.
    Takao K; Tani A; Suwa T; Kuwabara-Ohmura Y; Nonomura K; Liu Y; Kato T; Mizuno M; Hirota T; Enya M; Iizuka K; Horikawa Y; Saigo C; Kito Y; Miyazaki T; Ohe N; Iwama T; Yabe D
    BMC Endocr Disord; 2021 Jan; 21(1):13. PubMed ID: 33430828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.